Cardiovascular (CVD) and oncological diseases (OD) are the main causes of death worldwide and account for a heavy burden on economy, disability and mortality in many countries. Clear understanding of the mechanisms shared by CVD and cancer is important for increasing the life span and quality of life in cancer survivors as well as for preventing comorbidities and correct instructing the patients about risk factors and lifestyle modifications. Both groups of diseases share risk factors, including smoking, obesity, diabetes mellitus, alcohol consumption, unhealthy diet, etc. Along with these factors, inflammation may play a key role as it promotes both types of diseases and accompanies obesity, diabetes mellitus, arterial hypertension, and dyslipidemia. Better understanding of the interaction between CVD and cancer will allow creating common effective diagnostic and preventive strategies and safe approaches to the treatment.

cardio

Кардиология

Kardiologiia

0022-90402412-5660

Kardiomag

10.18087/cardio.2020.9.n910

cardio-910

Research Article

ОБЗОРЫ

REVIEWS

Роль модифицируемых сердечно-сосудистых факторов риска в возникновении онкологических заболеваний

Role of modified cardiovascular risk factors in development of oncologic diseases

https://orcid.org/0000-0001-5294-1273

Зволинская

Е. Ю.

Zvolinskaya

E. Yu.

к.м.н.,ведущий научный сотрудник лаборатории междисциплинарного подхода в профилактике хронических неинфекционных заболеваний ФГБУ НМИЦ ПМ МЗ РФ

SPIN-код: 2746-5408

PhD., main researcher of Department of Rehabilitation and Secondary Prevention of Combined Pathology of National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation

ringva@mail.ru

https://orcid.org/0000-0001-7131-8049

Мамедов

М. Н.

Mamedov

M. N.

Заведующий лабораторией по разработке междисциплинарного подхода в профилактике хронических неинфекционных заболеваний ФГБУ НМИЦ ПМ МЗ РФ, доктор медицинских наук, профессор

SPIN-код: 6631-9718

PhD., MD, head of Department of Rehabilitation and Secondary Prevention of Combined Pathology of National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation

mmamedov@mail.ru

https://orcid.org/0000-0002-2459-7273

Потиевская

В. И.

Potievskaya

V. I.

д.м.н., главный научный сотрудник ФГБУ«НМИЦ радиологии» Минздрава России

PhD., MD, chief researcher of Federal State Budgetary Institution National Medical Radiology Research Center of the Health Ministry of Russia

vera.pot@mail.ru

https://orcid.org/0000-0001-7689-6032

Иванов

С. А.

Ivanov

S. A.

д.м.н., директор Медицинского радиологического научного центра им. А.Ф.Цыба – филиала ФГБУ«НМИЦ радиологии» Минздрава России

PhD., MD, director of A.F. Tsyb Medical Radiological Research Center the branch of Federal State Budgetary Institution National Medical Radiology Research Center of the Health Ministry of Russia

khrapovama@nmirc.ru

https://orcid.org/0000-0001-8784-8415

Каприн

А. Д.

Kaprin

A. D.

академик РАН, генеральный директор ФГБУ «НМИЦ радиологии» Минздрава России

PhD., MD, Academician of Russian Academy of Science, General director of Federal State Budgetary Institution National Medical Radiology Research Center of the Health Ministry of Russia

dr89031990702@gmail.com

ФГБУ «НМИЦ профилактической медицины» Минздрава РФ, Москва, РоссияРоссияNational Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare, Moscow, RussiaRussian Federation

ФГБУ «НМИЦ радиологии» Минздрава РФ, Москва, РоссияРоссияNational Medical Radiology Research Center of the Ministry of Healthcare, Moscow, RussiaRussian Federation

«МРНЦ им. А. Ф. Цыба», ФГБУ «НМИЦ радиологии» Минздрава РФ, Обнинск, РоссияРоссияMedical Radiological Research Center the branch of National Medical Radiology Research Center of the Ministry of Healthcare, Obninsk, RussiaRussian Federation

2020

14102020

609110121

2020

Kardiomag

https://cardio.elpub.ru/jour/about/submissions#copyrightNotice

https://cardio.elpub.ru/jour/article/view/910

Сердечно-сосудистые заболевания (ССЗ) и онкологические заболевания (ОЗ) являются ведущими причинами смерти во всем мире и обусловливают весомую нагрузку на экономику многих стран в плане инвалидизации населения и смертности. Для увеличения продолжительности и качества жизни пациентов, выживших после перенесенного онкологического заболевания, а также предупреждения возникновения коморбидной патологии, правильного ведения и корректного информирования пациентов о факторах риска и модификации образа жизни необходимо иметь четкое представление об общности механизмов возникновения ССЗ и рака. Известны общие факторы риска для обеих групп заболеваний: курение, ожирение, сахарный диабет, алкоголь, погрешности в питании и др. Наряду с этим одну из центральных ролей может играть воспаление, так как оно способствует возникновению обеих групп заболеваний и встречается в условиях ожирения, сахарного диабета, артериальной гипертензии и дислипидемии. Дальнейшее понимание взаимодействия между ССЗ и раком позволит создать общие эффективные диагностические и профилактические стратегии, а также безопасные подходы к лечению.

Cardiovascular (CVD) and oncological diseases (OD) are the main causes of death worldwide and account for a heavy burden on economy, disability and mortality in many countries. Clear understanding of the mechanisms shared by CVD and cancer is important for increasing the life span and quality of life in cancer survivors as well as for preventing comorbidities and correct instructing the patients about risk factors and lifestyle modifications. Both groups of diseases share risk factors, including smoking, obesity, diabetes mellitus, alcohol consumption, unhealthy diet, etc. Along with these factors, inflammation may play a key role as it promotes both types of diseases and accompanies obesity, diabetes mellitus, arterial hypertension, and dyslipidemia. Better understanding of the interaction between CVD and cancer will allow creating common effective diagnostic and preventive strategies and safe approaches to the treatment.

Факторы рискасердечно-сосудистые заболеванияонкология

Risk factorscardiovascular diseasescancer

Конфликт интересов не заявлен.

No conflict of interest is reported.

References1

World Health Organization. World health statistics 2018: monitoring health for the SDGs. 2018. ISBN 978-92-4-156558-5

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394–424. DOI: 10.3322/caac.21492

Lee H, Cho J, Shin DW, Lee S-P, Hwang S-S, Oh J et al. Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: A nationwide cohort study. Preventive Medicine. 2015;70:19–25. DOI: 10.1016/j.ypmed.2014.11.007

Федеральная служба государственной статистики. Статистика смертности по данным Росстат. Доступно на: https://rosinfostat.ru/smertnost/

Federal State Statistics Service. Death statistics according to Rosstat. Av. at: https://rosinfostat.ru/smertnost/.

Van Hemelrijck M, Folkvaljon Y, Adolfsson J, Akre O, Holmberg L, Garmo H et al. Causes of death in men with localized prostate cancer: a nationwide, population-based study. BJU International. 2016;117(3):507–14. DOI: 10.1111/bju.13059

Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED et al. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger. Circulation. 2018;138(7):727–34. DOI: 10.1161/CIRCULATIONAHA.118.035516

Coutinho AD, Makenbaeva D, Farrelly E, Landsman-Blumberg PB, Lenihan D. Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United States. Clinical Lymphoma, Myeloma & Leukemia. 2017;17(10):676–83. DOI: 10.1016/j.clml.2017.06.011

Buddeke J, Bots ML, van Dis I, Liem A, Visseren FLJ, Vaartjes I. Trends in comorbidity in patients hospitalised for cardiovascular disease. International Journal of Cardiology. 2017;248:382–8. DOI: 10.1016/j.ijcard.2017.06.106

Al-Kindi SG, Oliveira GH. Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer. Mayo Clinic Proceedings. 2016;91(1):81–3. DOI: 10.1016/j.mayocp.2015.09.009

Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular Disease Mortality Among Breast Cancer Survivors: Epidemiology. 2016;27(1):6–13. DOI: 10.1097/EDE.0000000000000394

Haque R, Prout M, Geiger AM, Kamineni A, Thwin SS, Avila C et al. Comorbidities and cardiovascular disease risk in older breast cancer survivors. The American Journal of Managed Care. 2014;20(1):86–92. PMID: 24512167

Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ et al. Patients With Heart Failure Have an Increased Risk of Incident Cancer. Journal of the American College of Cardiology. 2013;62(10):881–6. DOI: 10.1016/j.jacc.2013.04.088

Бойцов С.А., Ипатов П.В., Калинина A.M., Вергазова Э.К., Ткачева О.Н., Гамбарян М.Г. и др. Организация проведения диспансеризации определенных групп взрослого населения. Методические рекомендации по практической реализации приказа Минздрава России от 3 февраля 2015 года №36АН «Об утверждении порядка проведения диспансеризации определенных групп взрослого населения». – М. 2015, – 111с. Утверждены главным специалистом по профилактической медицине Минздрава России 23 марта 2015 года. Доступно на: http://docs.cntd.ru/document/420265578

Boytsov S.A., Ipatov P.V., Kalinina A.M., Vergazova E.K., Tkacheva O.N., Gambaryan M.G. et al. Organization of medical examinations for certain groups of the adult population. Methodological recommendations for practical implementation of order of Ministry of health of Russian Federation of February 3, 2015 N 36an “on approval of the procedure for conducting medical examinations of certain groups of adult population”. - M. 2015, - 111c. Approved by the chief specialist in preventive medicine of the Russian Ministry of health on March 23, 2015. Av. at: http://docs.cntd.ru/document/420265578.

Зволинская Е.Ю., Кимициди М.Г., Александров А.А. Анализ распространенности факторов риска сердечно-сосудистых заболеваний у студентов. Профилактическая медицина. 2015;18(6):53-7

Zvolinskaia E.Yu., Kimitsidi M.G., Aleksandrov A.A. Analysis of the prevalence of cardiovascular risk factors in students. Russian Journal of Preventive Medicine and Public Health. 2015;18(6):53–7.

Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016;133(11):1104–14. DOI: 10.1161/CIRCULATIONAHA.115.020406

Frayn K, Bernard S, Spalding K, Arner P. Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia. Journal of the American Heart Association. 2012;1(6):e003467. DOI: 10.1161/JAHA.112.003467

Rodriguez-Iturbe B, Pons H, Quiroz Y, Johnson RJ. The Immunological Basis of Hypertension. American Journal of Hypertension. 2014;27(11):1327–37. DOI: 10.1093/ajh/hpu142

Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I et al. Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target. Current Atherosclerosis Reports. 2014;16(9):435. DOI: 10.1007/s11883-014-0435-z

Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K et al. High-Sensitivity C-Reactive Protein and Cardiovascular Disease. Journal of the American College of Cardiology. 2013;62(5):397–408. DOI: 10.1016/j.jacc.2013.05.016

Nishida Y, Kubota Y, Iso H, Tamakoshi A, the JACC Study Group. Self-Reported Eczema in Relation with Mortality from Cardiovascular Disease in Japanese: the Japan Collaborative Cohort Study. Journal of Atherosclerosis and Thrombosis. 2019;26(9):775–82. DOI: 10.5551/jat.46383

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. 2017;377(12):1119–31. DOI: 10.1056/NEJMoa1707914

Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. The Lancet. 2017;390(10105):1833–42. DOI: 10.1016/S0140-6736(17)32247-X

Kamp DW, Shacter E, Weitzman SA. Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park, N.Y.). 2011;25(5):400–10, 413. PMID: 21710835

Choudhury AR, Singh KK. Mitochondrial determinants of cancer health disparities. Seminars in Cancer Biology. 2017;47:125–46. DOI: 10.1016/j.semcancer.2017.05.001

Birru Talabi M, Mackey RH, Kuller LH, Dorman JS, Deane KD, Robinson WH et al. Human Leukocyte Antigen Shared Epitope and Inflammation, Cardiovascular Disease, Cancer, and Mortality Among Postmenopausal Women in the Women’s Health Initiative Rheumatoid Arthritis Study. American Journal of Epidemiology. 2017;186(2):245–54. DOI: 10.1093/aje/kwx087

Herrero Rivera D, Nieto-Guerrero Gómez JM, Cacicedo Fernández de Bobadilla J, Delgado D, Rivin del Campo E, Praena-Fernández JM et al. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment. Clinical and Translational Oncology. 2019;21(9):1220–30. DOI: 10.1007/s12094-019-02047-5

Гендлин Г.Е., Рязанцева Е. Е Хроническая сердечная недостаточность и риск онкологических заболеваний: существует ли взаимосвязь? Атмосфера. Новости кардиологии. 2013;4:21-4

Gendlin G.E., Ryazanceva E.E. Chronic heart failure and cancer risk: is there a relationship? Atmosphere. Cardiology news. 2013;4:21–4.

Thanan R, Oikawa S, Hiraku Y, Ohnishi S, Ma N, Pinlaor S et al. Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer. International Journal of Molecular Sciences. 2014;16(1):193–217. DOI: 10.3390/ijms16010193

Tan BL, Norhaizan ME, Liew W-P-P. Nutrients and Oxidative Stress: Friend or Foe? Oxidative Medicine and Cellular Longevity. 2018;2018:9719584. DOI: 10.1155/2018/9719584

Litwin SE. Cardiac Remodeling in Obesity. JACC: Cardiovascular Imaging. 2010;3(3):275–7. DOI: 10.1016/j.jcmg.2009.12.004

De Onis M, Lobstein T. Defining obesity risk status in the general childhood population: Which cut-offs should we use? International Journal of Pediatric Obesity. 2010;5(6):458–60. DOI: 10.3109/17477161003615583

Laskey R, McCarroll M, von Gruenigen V. Obesity-related endometrial cancer: an update on survivorship approaches to reducing cardiovascular death. BJOG: An International Journal of Obstetrics & Gynaecology. 2016;123(2):293–8. DOI: 10.1111/1471-0528.13684

Dobbins M, Decorby K, Choi BCK. The Association between Obesity and Cancer Risk: A Meta-Analysis of Observational Studies from 1985 to 2011. ISRN Preventive Medicine. 2013;2013:680536. DOI: 10.5402/2013/680536

Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ et al. Body-Mass Index and Mortality among 1.46 Million White Adults. New England Journal of Medicine. 2010;363(23):2211–9. DOI: 10.1056/NEJMoa1000367

Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A et al. Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). JNCI: Journal of the National Cancer Institute. 2006;98(13):920–31. DOI: 10.1093/jnci/djj246

Caiazza F, Ryan EJ, Doherty G, Winter DC, Sheahan K. Estrogen Receptors and Their Implications in Colorectal Carcinogenesis. Frontiers in Oncology. 2015;5:19. DOI: 10.3389/fonc.2015.00019

Ackerman SE, Blackburn OA, Marchildon F, Cohen P. Insights into the Link Between Obesity and Cancer. Current Obesity Reports. 2017;6(2):195–203. DOI: 10.1007/s13679-017-0263-x

Stefanou N, Papanikolaou V, Furukawa Y, Nakamura Y, Tsezou A. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer. 2010;10(1):442. DOI: 10.1186/1471-2407-10-442

Hou N, Luo J-D. Leptin and cardiovascular diseases: Leptin and cardiovascular diseases. Clinical and Experimental Pharmacology and Physiology. 2011;38(12):905–13. DOI: 10.1111/j.1440-1681.2011.05619.x

Singh R, Devi S, Gollen R. Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life. Diabetes/Metabolism Research and Reviews. 2015;31(2):113–26. DOI: 10.1002/dmrr.2558

Alman AC, Talton JW, Wadwa RP, Urbina EM, Dolan LM, Hamman RF et al. Inflammation, adiposity, and progression of arterial stiffness in adolescents with type 1 diabetes: The SEARCH CVD Study. Journal of Diabetes and its Complications. 2018;32(11):995–9. DOI: 10.1016/j.jdiacomp.2018.08.004

Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. DOI: 10.1136/bmj.g7607

Nagle CM, Crosbie EJ, Brand A, Obermair A, Oehler MK, Quinn M et al. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer. Gynecologic Oncology. 2018;150(1):99–105. DOI: 10.1016/j.ygyno.2018.04.006

Chen W, Wang S, Tian T, Bai J, Hu Z, Xu Y et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. European Journal of Human Genetics. 2009;17(12):1668–75. DOI: 10.1038/ejhg.2009.86

Reed MJ, Beranek PA, Ghilchik MW, James VH. Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer. European Journal of Cancer & Clinical Oncology. 1986;22(11):1395–400. DOI: 10.1016/0277-5379(86)90151-3

Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study: Menopause. 2018;25(1):11– 20. DOI: 10.1097/GME.0000000000000956

Jaroch J, Rzyczkowska B, Bociąga Z, Łoboz-Rudnicka M, Kruszyńska E, Rychard W et al. Arterial–atrial coupling in untreated hypertension. Blood Pressure. 2015;24(2):72–8. DOI: 10.3109/08037051.2014.986929

Stocks T, Van Hemelrijck M, Manjer J, Bjørge T, Ulmer H, Hallmans G et al. Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project. Hypertension. 2012;59(4):802–10. DOI: 10.1161/HYPERTENSIONAHA.111.189258

Kang YS, Park YG, Kim BK, Han SY, Jee YH, Han KH et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. Journal of Molecular Endocrinology. 2006;36(2):377–88. DOI: 10.1677/jme.1.02033

Zhang P-Y, Xu X, Li X-C. Cardiovascular diseases: oxidative damage and antioxidant protection. European Review for Medical and Pharmacological Sciences. 2014;18(20):3091–6. PMID: 25392110

Radišauskas R, Kuzmickienė I, Milinavičienė E, Everatt R. Hypertension, serum lipids and cancer risk: A review of epidemiological evidence. Medicina. 2016;52(2):89–98. DOI: 10.1016/j.medici.2016.03.002

Lyu Z, Li N, Wang G, Feng X, Chen S, Su K et al. Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort study. International Journal of Cancer. 2019;144(12):2972–84. DOI: 10.1002/ijc.32051

His M, Dartois L, Fagherazzi G, Boutten A, Dupré T, Mesrine S et al. Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study. Cancer Causes & Control. 2017;28(1):77–88. DOI: 10.1007/s10552-016-0832-4

Waluga M, Zorniak M, Fichna J, Kukla M, Hartleb M. Pharmacological and dietary factors in prevention of colorectal cancer. Journal of Physiology and Pharmacology. 2018;69(3). DOI: 10.26402/jpp.2018.3.02

Warner M, Gustafsson J-A. On Estrogen, Cholesterol Metabolism, and Breast Cancer. New England Journal of Medicine. 2014;370(6):572–3. DOI: 10.1056/NEJMcibr1315176

Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F, the PRACTICAL Consortium et al. Shared common variants in prostate cancer and blood lipids. International Journal of Epidemiology. 2014;43(4):1205–14. DOI: 10.1093/ije/dyu090

Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes. Journal of the American College of Cardiology. 2015;66(12):1378–91. DOI: 10.1016/j.jacc.2015.07.037

Conklin DJ, Schick S, Blaha MJ, Carll A, DeFilippis A, Ganz P et al. Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation. American Journal of Physiology-Heart and Circulatory Physiology. 2019;316(4):H801–27. DOI: 10.1152/ajpheart.00591.2018

Cifkova R, Pitha J, Krajcoviechova A, Kralikova E. Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach. International Journal of Cardiology. 2019;286:214–9. DOI: 10.1016/j.ijcard.2019.01.039

Всемирная Организация Здравоохранения. Европейское бюро. Глобальный опрос взрослого населения о потреблении табака: Краткий обзор, 2016 г. Доступно на: https://www.who.int/tobacco/surveillance/survey/gats/gats_2016-rus-executive-summary-Ru.pdf

World Health Organisation. European Bureau. A global poll of adult population about tobacco consumption: Brief overview, 2016. Av. at: https://www.who.int/tobacco/surveillance/survey/gats/gats_2016-rus-executive-summary-Ru.pdf.

Джемал А., Винеис П., Брей Ф., Торре Л., Форман Д. Атлас по онкологии. Издание второе. - Атланта: Американское онкологическое общество; 2014. – 135с.. ISBN 978-1-60443-228-2

Jemal A, Vineis P, Bray F, Torre L, Forman D. The cancer atlas. 2nd edition. -Atlanta: American Cancer Society;2016. - 135 p. ISBN 978-1-60443-228-2

Kitami M, Ali MK. Tobacco, Metabolic and Inflammatory Pathways, and CVD Risk. Global Heart. 2012;7(2):121–8. DOI: 10.1016/j.gheart.2012.06.004

USDA. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Part D, Chapter 2. Dietary patterns, foods and nutrients, and health outcomes. Av. at: https://ods.od.nih.gov/pubs/2015_dgac_scientific_report.pdf.2015.

Magalhães B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. European Journal of Cancer Prevention. 2012;21(1):15–23. DOI: 10.1097/CEJ.0b013e3283472241

Garcia-Larsen V, Morton V, Norat T, Moreira A, Potts JF, Reeves T et al. Dietary patterns derived from principal component analysis (PCA) and risk of colorectal cancer: a systematic review and metaanalysis. European Journal of Clinical Nutrition. 2019;73(3):366–86. DOI: 10.1038/s41430-018-0234-7

Stampfer M, Jahn JL. Partnerships for Promoting Prevention. Circulation. 2013;127(12):1267–9. DOI: 10.1161/CIRCULATIONAHA.113.001288

Wang T, Lee HG. Advances in Research on cis-9, trans-11 Conjugated Linoleic Acid: A Major Functional Conjugated Linoleic Acid Isomer. Critical Reviews in Food Science and Nutrition. 2015;55(5):720–31. DOI: 10.1080/10408398.2012.674071

Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G. Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis. Nutrients. 2017;9(10):1063. DOI: 10.3390/nu9101063

Wood AD, Strachan AA, Thies F, Aucott LS, Reid DM, Hardcastle AC et al. Patterns of dietary intake and serum carotenoid and tocopherol status are associated with biomarkers of chronic low-grade systemic inflammation and cardiovascular risk. British Journal of Nutrition. 2014;112(8):1341–52. DOI: 10.1017/S0007114514001962

Lordan R, Tsoupras A, Zabetakis I. The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment. Advances in Nutrition. 2019;10(1):148–64. DOI: 10.1093/advances/nmy090

Baena Ruiz R, Salinas Hernández P. Diet and cancer: Risk factors and epidemiological evidence. Maturitas. 2014;77(3):202–8. DOI: 10.1016/j.maturitas.2013.11.010

Salehi B, Martorell M, Arbiser J, Sureda A, Martins N, Maurya P et al. Antioxidants: Positive or Negative Actors? Biomolecules. 2018;8(4):124. DOI: 10.3390/biom8040124

Toma A, Paré G, Leong DP. Alcohol and Cardiovascular Disease: How Much is Too Much? Current Atherosclerosis Reports. 2017;19(3):13. DOI: 10.1007/s11883-017-0647-0

O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and Cardiovascular Health: The Dose Makes the Poison… or the Remedy. Mayo Clinic Proceedings. 2014;89(3):382–93. DOI: 10.1016/j.mayocp.2013.11.005

Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V et al. Light alcohol drinking and cancer: a meta-analysis. Annals of Oncology. 2013;24(2):301–8. DOI: 10.1093/annonc/mds337

Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A et al. Alcohol and cause-specific mortality in Russia: a retrospective case–control study of 48 557 adult deaths. The Lancet. 2009;373(9682):2201–14. DOI: 10.1016/S0140-6736(09)61034-5

Matejcic M, Gunter MJ, Ferrari P. Alcohol metabolism and oesophageal cancer: a systematic review of the evidence. Carcinogenesis. 2017;38(9):859–72. DOI: 10.1093/carcin/bgx067

Che L, Li D. The Effects of Exercise on Cardiovascular Biomarkers: New Insights, Recent Data, and Applications. In: Exercise for Cardiovascular Disease Prevention and Treatment. Series Title: Advances in Experimental Medicine and Biology. [ISBN: 978-981-10-4306- 2. DOI: 10.1007/978-981-10-4307-9_3]. Xiao J, editor -Singapore: Springer Singapore;2017.

Nakitanda A.O., Xuereb G., Armstrong T. Растущее бремя неинфекционных заболеваний и роль физической активности. Профилактическая медицина. 2014;17(1):12-7

Nakitanda A.O., Xuereb G., Armstrong T. The increasing burden of non communicable diseases and the role of physical activity. Russian Journal of Preventive Medicine and Public Health. 2014;17(1):12–7.

Schmid D, Behrens G, Keimling M, Jochem C, Ricci C, Leitzmann M. A systematic review and meta-analysis of physical activity and endometrial cancer risk. European Journal of Epidemiology. 2015;30(5):397–412. DOI: 10.1007/s10654-015-0017-6

Заридзе Д.Г Профилактика рака. Руководство для врачей. - М.:ИМА-Пресс, 2009. - 224с. ISBN 978-5-904356-05-7

Zaridze D.G. Cancer prophylactics. Guidelines for doctors. -M.: IMAPress;2009. - 224 p. ISBN 978-5-904356-05-7

MacCallum-Carter L. Как найти выход из эпидемии физической пассивности. Профилактическая медицина. 2014;17(1):28-30

MacCallum-Carter L. Solving the Physical Inactivity Epidemic. Russian Journal of Preventive Medicine and Public Health. 2014;17(1):28–30.

Eriksson M, Johnson O, Boman K, Hallmans G, Hellsten G, Nilsson TK et al. Improved fibrinolytic activity during exercise may be an effect of the adipocyte-derived hormones leptin and adiponectin. Thrombosis Research. 2008;122(5):701–8. DOI: 10.1016/j.thromres.2008.01.010

Howard BJ, Hurtig-Wennlöf A, Olsson LA, Nilsson TK, Dunstan DW, Wennberg P. Self-Reported Sitting Time, Physical Activity and Fibrinolytic and Other Novel Cardio-Metabolic Biomarkers in Active Swedish Seniors. PLOS ONE. 2016;11(9):e0163409. DOI: 10.1371/journal.pone.0163409

Avan A, Tavakoly Sany SB, Ghayour-Mobarhan M, Rahimi HR, Tajfard M, Ferns G. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. Journal of Cellular Physiology. 2018;233(11):8508– 25. DOI: 10.1002/jcp.26791

The authors declare that there are no conflicts of interest present.